Spyre Therapeutics Earnings
NASDAQ: SYREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.79
Spyre Therapeutics earnings summary
Spyre Therapeutics is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-0.79. In its most recent report on May 5, 2026 (Q1 2026), SYRE posted EPS of $-0.74. Across the last 14 reports, SYRE shares moved an average of 11.5% (in either direction) in the first trading session after results, rising 7 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
SYRE earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| May 5, 2026 | — | $-0.74 | — | -0.2% |
| Nov 7, 2024 | — | $1.06 | — | -26.2% |
| Aug 7, 2024 | — | $0.59 | — | +5.0% |
| May 9, 2024 | — | $0.72 | — | +2.4% |
| Feb 29, 2024 | — | $-22.35 | — | +26.9% |
| Nov 9, 2023 | — | $0.86 | — | +8.0% |
| Aug 11, 2023 | — | $40.14 | — | -2.0% |
| May 11, 2023 | — | $-4.89 | — | -4.6% |
| Mar 2, 2023 | — | $-19.38 | — | -3.6% |
| Nov 3, 2022 | — | $-4.84 | — | +23.4% |
| Aug 4, 2022 | — | $-0.27 | — | +17.1% |
| May 5, 2022 | — | $-0.37 | — | -0.7% |
| Mar 8, 2022 | — | $-0.31 | — | +36.7% |
| Nov 4, 2021 | — | $-0.31 | — | -3.8% |
| Aug 5, 2021 | — | $-0.10 | — | — |
| May 10, 2021 | — | $-0.28 | — | — |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.